{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T12:40:06Z","timestamp":1748522406234,"version":"3.41.0"},"reference-count":80,"publisher":"IOP Publishing","issue":"4","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/iopscience.iop.org\/page\/copyright"},{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/iopscience.iop.org\/info\/page\/text-and-data-mining"}],"funder":[{"name":"DST New delhi","award":["CRG\/2022\/004594"],"award-info":[{"award-number":["CRG\/2022\/004594"]}]}],"content-domain":{"domain":["iopscience.iop.org"],"crossmark-restriction":false},"short-container-title":["Biomed. Mater."],"published-print":{"date-parts":[[2025,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Ovarian cancer is the most prevalent fatal, gynecological malignancy in women, resulting in poor survival rate (fifth in cancer deaths) due to its asymptomatic nature. Unmet medical challenges for ovarian cancer are associated with several constraints such as poor bioavailability, nonspecificity, and toxicity-related issues. Targeted drug delivery systems may overcome the existing limitations. Utilizing the concept of overexpression of folate receptors (FRs) in ovarian carcinoma, we have designed FRs-targeted drug delivery systems (AgNNPs-FA) by combining silver nitroprusside nanoparticles (AgNNPs) because of their inherent anticancer properties, as established by our group, and folic acid (FA) as targeting agent that attack FRs in this study. Initially, both AgNNPs and AgNNPs\u2013FA were designed and later characterized using several analytical tools such as dynamic light scattering, x-ray diffraction, scanning electron microscopy, transmission electron microscopy, thermogravimetric analysis, high-performance liquid chromatography, and Fourier transform\u2013infrared spectroscopy, etc. The <jats:italic>in vitro<\/jats:italic> cell viability assay in a Chinese hamster ovary cell line suggests the biocompatible nature of AgNNPs\u2013FA. The targeted anticancer activity of the AgNNPs\u2013FA is established in human ovarian adenocarcinoma (SK-OV-3) via several <jats:italic>in vitro<\/jats:italic> assays and compared with AgNNPs. All <jats:italic>in vitro<\/jats:italic> assays (cell viability assay, thymidine incorporation assay, scratch assay, cell cycle, apoptosis assay, and tunnel assay) in SK-OV-3 and <jats:italic>in vivo<\/jats:italic> experiments (chorioallantoic membrane assay) in fertilized eggs with AgNNPs\u2013FA exhibit more anticancer activity in a targeted fashion than AgNNPs. The plausible mechanisms behind the anticancer activity of the nanoparticles were demonstrated using the ROS assay (DCFDA and DHE staining), JC-1 staining, immunocytochemistry staining (Ki-67), and Western blot analysis. The results altogether support the idea that this targeted drug delivery system could be used as an alternative treatment strategy for ovarian cancer and other cancers with the overexpression of FRs.<\/jats:p>","DOI":"10.1088\/1748-605x\/add2b9","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T08:13:59Z","timestamp":1746087239000},"page":"045007","update-policy":"https:\/\/doi.org\/10.1088\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Folic acid\u2013encapsulated silver nitroprusside nanoparticles for targeted therapy in ovarian cancer"],"prefix":"10.1088","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-6642-8223","authenticated-orcid":true,"given":"Arti","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8984-3415","authenticated-orcid":true,"given":"Swapnali","family":"Londhe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4998-5221","authenticated-orcid":false,"given":"Sanchita","family":"Tripathy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0152-5074","authenticated-orcid":true,"given":"Proma","family":"Nagchowdhury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9453-6524","authenticated-orcid":true,"given":"Chitta Ranjan","family":"Patra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"266","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"key":"bmmadd2b9bib1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.972341","article-title":"Ovarian cancer subtypes based on the regulatory genes of RNA modifications: novel prediction model of prognosis","volume":"13","author":"Zheng","year":"2022","journal-title":"Front. Endocrinol."},{"key":"bmmadd2b9bib2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.5114\/pm.2023.128661","article-title":"Epidemiology and risk factors for ovarian cancer","volume":"22","author":"Ali","year":"2023","journal-title":"Menopause Rev.\/Przeglad Menopauzalny"},{"article-title":"CANCER TOMORROW, International Agency for Reserch on Cancer","year":"2022","author":"WHO","key":"bmmadd2b9bib3"},{"key":"bmmadd2b9bib4","first-page":"119","article-title":"Trends in cancer incidence in female breast, cervix uteri, corpus uteri, and ovary in India","volume":"9","author":"Yeole","year":"2008","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"bmmadd2b9bib5","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3322\/caac.21559","article-title":"Epithelial ovarian cancer: evolution of management in the era of precision medicine","volume":"69","author":"Lheureux","year":"2019","journal-title":"CA Cancer J. Clin."},{"article-title":"GRAND VIEW RESEARCH, Pharmaceuticals, Ovarian Cancer Drugs Market Size And Share Report, 2030","year":"2022","author":"Research","key":"bmmadd2b9bib6"},{"key":"bmmadd2b9bib7","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s11033-023-09096-8","article-title":"Revolutionizing cancer care strategies: immunotherapy, gene therapy, and molecular targeted therapy","volume":"51","author":"Zafar","year":"2024","journal-title":"Mol. Biol. Rep."},{"key":"bmmadd2b9bib8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13048-024-01359-7","article-title":"From clinical management to personalized medicine: novel therapeutic approaches for ovarian clear cell cancer","volume":"17","author":"Liu","year":"2024","journal-title":"J. Ovarian Res."},{"key":"bmmadd2b9bib9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.pdpdt.2011.08.003","article-title":"Photodiagnosis and photodynamic therapy of peritoneal metastasis of ovarian cancer","volume":"9","author":"Guyon","year":"2012","journal-title":"Photodyn. Ther."},{"key":"bmmadd2b9bib10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1586\/14737140.6.1.43","article-title":"Hormonal therapy in epithelial ovarian cancer","volume":"6","author":"Rao","year":"2006","journal-title":"Expert Rev. Anticancer Ther."},{"key":"bmmadd2b9bib11","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.canlet.2014.03.013","article-title":"Multi-drug resistance in cancer chemotherapeutics: mechanisms and lab approaches","volume":"347","author":"Wu","year":"2014","journal-title":"Cancer Lett."},{"key":"bmmadd2b9bib12","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.3390\/molecules25092193","article-title":"Therapeutic nanoparticles and their targeted delivery applications","volume":"25","author":"Yetisgin","year":"2020","journal-title":"Molecules"},{"key":"bmmadd2b9bib13","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1007\/s00449-020-02330-8","article-title":"Selected nanotechnologies and nanostructures for drug delivery, nanomedicine and cure","volume":"43","author":"Khan","year":"2020","journal-title":"Bioprocess. Biosyst. Eng."},{"key":"bmmadd2b9bib14","doi-asserted-by":"publisher","first-page":"3218","DOI":"10.1080\/10717544.2022.2132032","article-title":"Nanotechnological approaches for diagnosis and treatment of ovarian cancer: a review of recent trends","volume":"29","author":"Ding","year":"2022","journal-title":"Drug Deliv."},{"key":"bmmadd2b9bib15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/012210299X310916240801111606","article-title":"Metal Nanoparticles for Ovarian Cancer Therapy","volume":"2","author":"Patel","year":"2024","journal-title":"Curr. Indian Sci."},{"key":"bmmadd2b9bib16","doi-asserted-by":"publisher","first-page":"3482","DOI":"10.3390\/molecules29153482","article-title":"A comprehensive review of nanoparticles: from classification to application and toxicity","volume":"29","author":"Eker","year":"2024","journal-title":"Molecules"},{"key":"bmmadd2b9bib17","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.addr.2012.08.015","article-title":"Surface engineering of inorganic nanoparticles for imaging and therapy","volume":"65","author":"Nam","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"bmmadd2b9bib18","doi-asserted-by":"publisher","DOI":"10.1002\/adtp.202200293","article-title":"Design of lysozyme\u2010templated biocompatible fluorescent nanocomposites and their potential applications for cell imaging, hydrogen peroxide sensing, and cancer therapy","volume":"6","author":"Das","year":"2023","journal-title":"Adv. Ther."},{"key":"bmmadd2b9bib19","doi-asserted-by":"publisher","first-page":"10017","DOI":"10.1039\/D3NR00221G","article-title":"Silver nitroprusside nanoparticles for breast cancer therapy: in vitro and in vivo approach","volume":"15","author":"Londhe","year":"2023","journal-title":"Nanoscale"},{"key":"bmmadd2b9bib20","doi-asserted-by":"publisher","first-page":"13580","DOI":"10.1039\/D4NR01857E","article-title":"Copper nitroprusside analogue nanoparticles against melanoma: detailed in vitro and in vivo investigation","volume":"16","author":"Tripathy","year":"2024","journal-title":"Nanoscale"},{"key":"bmmadd2b9bib21","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e25521","article-title":"A critical review on metal-organic frameworks (MOFs) based nanomaterials for biomedical applications: designing, recent trends, challenges, and prospects","volume":"10","author":"Sadiq","year":"2024","journal-title":"Heliyon"},{"key":"bmmadd2b9bib22","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.3390\/ph16101410","article-title":"Current overview of metal nanoparticles\u2019 synthesis, characterization, and biomedical applications, with a focus on silver and gold nanoparticles","volume":"16","author":"Burlec","year":"2023","journal-title":"Pharmaceuticals"},{"key":"bmmadd2b9bib23","doi-asserted-by":"publisher","DOI":"10.1016\/j.hybadv.2024.100184","article-title":"Silver nanoparticle for biomedical applications: a review","volume":"6","author":"Meher","year":"2024","journal-title":"Hybrid Adv."},{"first-page":"247","year":"2023","author":"Londhe","key":"bmmadd2b9bib24"},{"key":"bmmadd2b9bib25","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/5107485","article-title":"Heterogeneous responses of ovarian cancer cells to silver nanoparticles as a single agent and in combination with cisplatin","volume":"2017","author":"Fahrenholtz","year":"2017","journal-title":"J. Nanomater."},{"key":"bmmadd2b9bib26","doi-asserted-by":"publisher","first-page":"6487","DOI":"10.2147\/IJN.S135482","article-title":"Silver nanoparticles enhance the apoptotic potential of gemcitabine in human ovarian cancer cells: combination therapy for effective cancer treatment","volume":"12","author":"Yuan","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"bmmadd2b9bib27","doi-asserted-by":"publisher","first-page":"5057","DOI":"10.1021\/acsabm.4c00597","article-title":"Therapeutic potential of silver nitroprusside nanoparticles for melanoma","volume":"7","author":"Londhe","year":"2024","journal-title":"ACS Appl. Bio Mater."},{"key":"bmmadd2b9bib28","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3390\/toxics9080195","article-title":"State of the art on toxicological mechanisms of metal and metal oxide nanoparticles and strategies to reduce toxicological risks","volume":"9","author":"Garc\u00eda-Torra","year":"2021","journal-title":"Toxics"},{"key":"bmmadd2b9bib29","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41571-020-0339-5","article-title":"Exploiting the folate receptor \u03b1 in oncology","volume":"17","author":"Scaranti","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"bmmadd2b9bib30","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/s41416-022-02031-x","article-title":"Folate receptor alpha in ovarian cancer tissue and patient serum is associated with disease burden and treatment outcomes","volume":"128","author":"Bax","year":"2023","journal-title":"Br. J. Cancer"},{"key":"bmmadd2b9bib31","doi-asserted-by":"publisher","DOI":"10.3402\/nano.v3i0.18496","article-title":"Utilizing the folate receptor for active targeting of cancer nanotherapeutics","volume":"3","author":"Zwicke","year":"2012","journal-title":"Nano Rev."},{"key":"bmmadd2b9bib32","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10555-014-9539-8","article-title":"Role of the folate receptor in ovarian cancer treatment: evidence, mechanism, and clinical implications","volume":"34","author":"Vergote","year":"2015","journal-title":"Cancer Metastasis Rev."},{"key":"bmmadd2b9bib33","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1634\/theoncologist.2018-0459","article-title":"Is targeting the folate receptor in ovarian cancer coming of age?","volume":"24","author":"Birrer","year":"2019","journal-title":"Oncologist"},{"key":"bmmadd2b9bib34","doi-asserted-by":"publisher","first-page":"52553","DOI":"10.18632\/oncotarget.9651","article-title":"Targeting folate receptor alpha for cancer treatment","volume":"7","author":"Cheung","year":"2016","journal-title":"Oncotarget"},{"key":"bmmadd2b9bib35","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1039\/B913224D","article-title":"Fabrication and functional characterization of goldnanoconjugates for potential application in ovarian cancer","volume":"20","author":"Patra","year":"2010","journal-title":"J. Mater. Chem."},{"key":"bmmadd2b9bib36","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1038\/s41598-023-28424-3","article-title":"Folate receptor targeted nanoparticles containing niraparib and doxorubicin as a potential candidate for the treatment of high grade serous ovarian cancer","volume":"13","author":"Wang","year":"2023","journal-title":"Sci. Rep."},{"key":"bmmadd2b9bib37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-016-2206-4","article-title":"Folic acid tagged nanoceria as a novel therapeutic agent in ovarian cancer","volume":"16","author":"Hijaz","year":"2016","journal-title":"BMC Cancer"},{"key":"bmmadd2b9bib38","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.1021\/acsbiomaterials.8b00759","article-title":"Ag2 [Fe (CN)5NO] nanoparticles exhibit antibacterial activity and wound healing properties","volume":"4","author":"Rao","year":"2018","journal-title":"ACS Biomat. Sci. Eng."},{"key":"bmmadd2b9bib39","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3390\/ph3030482","article-title":"The chick embryo chorioallantoic membrane as an in vivo assay to study antiangiogenesis","volume":"3","author":"Ribatti","year":"2010","journal-title":"Pharmaceuticals"},{"key":"bmmadd2b9bib40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1756-9966-29-23","article-title":"Anti-HER-2 engineering antibody ChA21 inhibits growth and induces apoptosis of SK-OV-3 cells","volume":"29","author":"Zhang","year":"2010","journal-title":"J. Exp Clin. Cancer Res."},{"key":"bmmadd2b9bib41","doi-asserted-by":"publisher","first-page":"e3128","DOI":"10.21769\/BioProtoc.3128","article-title":"Analysis of the mitochondrial membrane potential using the cationic JC-1 dye as a sensitive fluorescent probe","volume":"9","author":"Sivandzade","year":"2019","journal-title":"Bio-protocol"},{"key":"bmmadd2b9bib42","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioadv.2024.213832","article-title":"ROS mediated Cu[Fe(CN)5NO] nanoparticles for triple negative breast cancer: a detailed study in preclinical mouse model","volume":"160","author":"Tripathy","year":"2024","journal-title":"Biomater. Adv."},{"key":"bmmadd2b9bib43","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s11164-022-04888-2","article-title":"Bio-synthesis of silver nanoparticles using leaf extract of Rhaphidophora pertusa and its characterization, antimicrobial, antioxidant and cytotoxicity activities","volume":"49","author":"Deivanathan","year":"2023","journal-title":"Res. Chem. Intermed."},{"key":"bmmadd2b9bib44","doi-asserted-by":"publisher","DOI":"10.1016\/j.physe.2021.114771","article-title":"Study of dielectric relaxation and polaron conductivity mechanism in sodium nitroprusside (SNP): na2 [Fe(CN)5 (NO)]\u00b72H2O","volume":"132","author":"Karoui","year":"2021","journal-title":"Physica E"},{"key":"bmmadd2b9bib45","doi-asserted-by":"publisher","first-page":"329","DOI":"10.36468\/pharmaceutical-sciences.654","article-title":"Strategic design of dicer substrate siRNA to mitigate the resistance mediated by ABCC1 in doxorubicinresistant breast cancer","volume":"82","author":"Gatta","year":"2020","journal-title":"Indian J. Pharm. Sci."},{"key":"bmmadd2b9bib46","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1021\/acsnano.2c06977","article-title":"Core, coating, or corona? The importance of considering protein coronas in nano-QSPR modeling of zeta potential","volume":"17","author":"Sengottiyan","year":"2023","journal-title":"ACS Nano"},{"key":"bmmadd2b9bib47","doi-asserted-by":"publisher","first-page":"371","DOI":"10.16984\/saufenbilder.60115","article-title":"Investigation of nano metal and metal oxide particles synthesis by using medium frequency-induction method","volume":"20","author":"Kartal","year":"2016","journal-title":"Sakarya Univ. J. Sci."},{"key":"bmmadd2b9bib48","doi-asserted-by":"publisher","DOI":"10.1016\/j.tca.2024.179813","article-title":"Pyrolysis of folic acid: identification of gaseous\/volatile products and structural evolution of N-doped graphitic carbon","volume":"739","author":"Magri","year":"2024","journal-title":"Thermochim. Acta"},{"key":"bmmadd2b9bib49","doi-asserted-by":"publisher","first-page":"17401","DOI":"10.1039\/C6DT03323G","article-title":"Folic acid conjugated Fe3O4 magnetic nanoparticles for targeted delivery of doxorubicin","volume":"45","author":"Rana","year":"2016","journal-title":"Dalton Trans."},{"key":"bmmadd2b9bib50","doi-asserted-by":"publisher","first-page":"671","DOI":"10.5740\/jaoacint.16-0239","article-title":"Development and validation of an RP-HPLC method for the determination of vinpocetine and folic acid in the presence of a vinpocetine alkaline degradation product in bulk and in capsule form","volume":"100","author":"Elkady","year":"2017","journal-title":"J. AOAC Int."},{"key":"bmmadd2b9bib51","first-page":"163","article-title":"RP-HPLC Method of the Estimation of Folic Acid in Tablets","volume":"5","author":"Alagi\u0107-D\u017eambi\u0107","year":"2020","journal-title":"Chemrj."},{"key":"bmmadd2b9bib52","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41420-022-01207-x","article-title":"Drug toxicity assessment: cell proliferation versus cell death","volume":"8","author":"Sazonova","year":"2022","journal-title":"Cell Death Discov."},{"key":"bmmadd2b9bib53","doi-asserted-by":"publisher","first-page":"38","DOI":"10.36000\/hbT.OH.2020.05.022","article-title":"Folate receptor \u03b1-a new target for an old enemy","volume":"5","author":"Ruf","year":"2020","journal-title":"Healthbook TIMES Oncol. Hematol."},{"key":"bmmadd2b9bib54","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/978-1-61779-080-5_36","article-title":"Drug design and testing: profiling of antiproliferative agents for cancer therapy using a cell-based methyl-[3H]-thymidine incorporation assay","volume":"731","author":"Griffiths","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"bmmadd2b9bib55","doi-asserted-by":"publisher","first-page":"4218","DOI":"10.1039\/C6CS00636A","article-title":"Cellular uptake of nanoparticles: journey inside the cell","volume":"46","author":"Behzadi","year":"2017","journal-title":"Chem. Soc. Rev."},{"key":"bmmadd2b9bib56","doi-asserted-by":"publisher","first-page":"5397","DOI":"10.1039\/d0cs01127d","article-title":"Understanding nanoparticle endocytosis to improve targeting strategies in nanomedicine","volume":"50","author":"Sousa de Almeida","year":"2021","journal-title":"Chem. Soc. Rev."},{"key":"bmmadd2b9bib57","doi-asserted-by":"publisher","first-page":"13602","DOI":"10.1016\/S0021-9258(18)68284-5","article-title":"Delivery of folates to the cytoplasm of MA104 cells is mediated by a surface membrane receptor that recycles","volume":"263","author":"Kamen","year":"1988","journal-title":"J. Biol. Chem."},{"key":"bmmadd2b9bib58","doi-asserted-by":"publisher","first-page":"505","DOI":"10.2174\/156800905774574048","article-title":"Cancer therapy through control of cell migration","volume":"5","author":"Levin","year":"2005","journal-title":"Curr. Cancer Drug Targets"},{"key":"bmmadd2b9bib59","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154854","article-title":"The pathophysiology of the cell cycle in cancer and treatment strategies using various cell cycle checkpoint inhibitors","volume":"251","author":"Almalki","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"bmmadd2b9bib60","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.842376","article-title":"Cancer and apoptosis: the apoptotic activity of plant and marine natural products and their potential as targeted cancer therapeutics","volume":"13","author":"Chaudhry","year":"2022","journal-title":"Front. Pharmacol."},{"key":"bmmadd2b9bib61","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1007\/s11033-018-4258-9","article-title":"An overview of apoptosis assays detecting DNA fragmentation","volume":"45","author":"Majtnerov\u00e1","year":"2018","journal-title":"Mol. Biol. Rep."},{"key":"bmmadd2b9bib62","doi-asserted-by":"publisher","first-page":"84","DOI":"10.2174\/2667387816666220506203123","article-title":"ROS modulating inorganic nanoparticles: a novel cancer therapeutic tool","volume":"16","author":"Amaldoss","year":"2022","journal-title":"Recent Adv. Drug Deliv. Formul."},{"key":"bmmadd2b9bib63","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.558932","article-title":"The prognostic relevance of the proliferation markers Ki-67 and Plk1 in early-stage ovarian cancer patients with serous, low-grade carcinoma based on mRNA and protein expression","volume":"10","author":"R\u00f6del","year":"2020","journal-title":"Front. Oncol."},{"key":"bmmadd2b9bib64","doi-asserted-by":"publisher","first-page":"e1398","DOI":"10.1038\/cddis.2014.363","article-title":"Targeting the actin cytoskeleton: selective antitumor action via trapping PKCvarepsilon","volume":"5","author":"Foerster","year":"2014","journal-title":"Cell Death Dis."},{"key":"bmmadd2b9bib65","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.1016\/j.semcancer.2015.03.001","article-title":"Broad targeting of resistance to apoptosis in cancer","volume":"35","author":"Mohammad","year":"2015","journal-title":"Sem. Cancer Biol."},{"key":"bmmadd2b9bib66","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-32480-5","article-title":"Apoptotic efficacy of multifaceted biosynthesized silver nanoparticles on human adenocarcinoma cells","volume":"8","author":"Plackal Adimuriyil George","year":"2018","journal-title":"Sci. Rep."},{"key":"bmmadd2b9bib67","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.drudis.2014.11.014","article-title":"Silver nanoparticles: synthesis, properties, and therapeutic applications","volume":"20","author":"Wei","year":"2015","journal-title":"Drug Discov. Today"},{"key":"bmmadd2b9bib68","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.985363","article-title":"The role of BCL-2 family proteins in regulating apoptosis and cancer therapy","volume":"12","author":"Qian","year":"2022","journal-title":"Front. Oncol."},{"key":"bmmadd2b9bib69","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.ejphar.2016.10.019","article-title":"Synergistic effect of piperine and paclitaxel on cell fate via cyt-c, Bax\/Bcl-2-caspase-3 pathway in ovarian adenocarcinomas SKOV-3 cells","volume":"791","author":"Pal","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"bmmadd2b9bib70","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a008672","article-title":"Cellular mechanisms controlling caspase activation and function","volume":"5","author":"Parrish","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"bmmadd2b9bib71","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/6235641","article-title":"Redox homeostasis and cellular antioxidant systems: crucial players in cancer growth and therapy","volume":"2016","author":"Marengo","year":"2016","journal-title":"Oxid Med. Cell Longev."},{"key":"bmmadd2b9bib72","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.freeradbiomed.2020.02.027","article-title":"Lipid peroxidation and ferroptosis: the role of GSH and GPx4","volume":"152","author":"Ursini","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"bmmadd2b9bib73","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.4238\/2015.March.30.3","article-title":"Inhibitor of signal transducer and activator of transcription 3 (STAT3) suppresses ovarian cancer growth, migration and invasion and enhances the effect of cisplatin in vitro","volume":"14","author":"Tang","year":"2015","journal-title":"Genet Mol. Res."},{"key":"bmmadd2b9bib74","doi-asserted-by":"publisher","first-page":"EC08","DOI":"10.7860\/JCDR\/2017\/24350.9381","article-title":"Diagnostic and prognostic significance of Ki-67 immunohistochemical expression in surface epithelial ovarian carcinoma","volume":"11","author":"Mahadevappa","year":"2017","journal-title":"J. Clin. Diagn. Res."},{"key":"bmmadd2b9bib75","doi-asserted-by":"publisher","first-page":"15344","DOI":"10.1073\/pnas.1411499111","article-title":"Investigating the optimal size of anticancer nanomedicine","volume":"111","author":"Tang","year":"2014","journal-title":"Proc. Natl Acad. Sci."},{"key":"bmmadd2b9bib76","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2022.103525","article-title":"Anticancer activity of silver nanoparticles from the aqueous extract of Dictyota ciliolata on non-small cell lung cancer cells","volume":"74","author":"Pavan","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"bmmadd2b9bib77","doi-asserted-by":"publisher","first-page":"19011","DOI":"10.1021\/acs.inorgchem.4c03425","article-title":"Investigating the size effect of metal\u2013organic frameworks in drug delivery and anticancer properties","volume":"63","author":"Tarasi","year":"2024","journal-title":"Inorg. Chem."},{"key":"bmmadd2b9bib78","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.jconrel.2022.12.028","article-title":"Applications and challenges of ultra-small particle size nanoparticles in tumor therapy","volume":"353","author":"Xu","year":"2023","journal-title":"J. Control Release"},{"key":"bmmadd2b9bib79","doi-asserted-by":"publisher","DOI":"10.4491\/eer.2023.549","article-title":"Review on metallic nanoparticles induced toxicity on renal function and overall health of kidneys","volume":"29","author":"Waris","year":"2024","journal-title":"Environ. Eng. Res."},{"key":"bmmadd2b9bib80","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3390\/jpm11060571","article-title":"Recent advances in tumor targeting via EPR effect for cancer treatment","volume":"11","author":"Subhan","year":"2021","journal-title":"J. Pers. Med."}],"container-title":["Biomedical Materials"],"original-title":[],"link":[{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/add2b9","content-type":"text\/html","content-version":"am","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/add2b9\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/add2b9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/add2b9\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/add2b9\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/add2b9\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/add2b9\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"similarity-checking"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/add2b9\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T12:18:13Z","timestamp":1748521093000},"score":1,"resource":{"primary":{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/add2b9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":80,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,5,29]]},"published-print":{"date-parts":[[2025,7,1]]}},"URL":"https:\/\/doi.org\/10.1088\/1748-605x\/add2b9","relation":{},"ISSN":["1748-6041","1748-605X"],"issn-type":[{"type":"print","value":"1748-6041"},{"type":"electronic","value":"1748-605X"}],"subject":[],"published":{"date-parts":[[2025,5,29]]},"assertion":[{"value":"Folic acid\u2013encapsulated silver nitroprusside nanoparticles for targeted therapy in ovarian cancer","name":"article_title","label":"Article Title"},{"value":"Biomedical Materials","name":"journal_title","label":"Journal Title"},{"value":"paper","name":"article_type","label":"Article Type"},{"value":"\u00a9 2025 IOP Publishing Ltd. All rights, including for text and data mining, AI training, and similar technologies, are reserved.","name":"copyright_information","label":"Copyright Information"},{"value":"2025-01-31","name":"date_received","label":"Date Received","group":{"name":"publication_dates","label":"Publication dates"}},{"value":"2025-04-30","name":"date_accepted","label":"Date Accepted","group":{"name":"publication_dates","label":"Publication dates"}},{"value":"2025-05-29","name":"date_epub","label":"Online publication date","group":{"name":"publication_dates","label":"Publication dates"}}]}}